A.P. Pharma, Inc. Regains Compliance With NASDAQ National Market Listing Requirements

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jan. 18, 2006--A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, announces that based on the Company’s recording of the gain on the sale of the royalty rights announced today, A.P. Pharma believes it has regained compliance for continued listing on the NASDAQ National Market by satisfying the NASDAQ’s minimum stockholders’ equity requirement of the NASDAQ National Marketplace Rule 4450(a)(3). NASDAQ will continue to monitor the Company’s ongoing compliance with the stockholders’ equity requirement.

MORE ON THIS TOPIC